Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M O'Conor

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Health Policy (Amsterdam, Netherlands)|February 6, 1997
Cost-utility analysis from a societal perspectiveM Johannesson, R M O'Conor
Journal of Health Economics|November 3, 1997
Measurement of consumer-patient preferences using a hybrid contingent valuation methodR M O'Conor, G C Blomquist
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 31, 1997
Incorporating future costs in medical cost-effectiveness analysis: implications for the cost-effectiveness of the treatment of hypertensionM Johannesson, D Meltzer, R M O'Conor
British Journal of Urology|November 14, 1997
Willingness to pay for reduced incontinence symptomsM Johannesson, R M O'Conor, G Kobelt-Nguyen, et al.
Pharmacoeconomics|May 27, 1999
Urge incontinence. Quality of life and patients' valuation of symptom reductionR M O'Conor, M Johannesson, S L Hass, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Health Policy (Amsterdam, Netherlands)|February 6, 1997
Cost-utility analysis from a societal perspectiveM Johannesson, R M O'Conor
Journal of Health Economics|November 3, 1997
Measurement of consumer-patient preferences using a hybrid contingent valuation methodR M O'Conor, G C Blomquist
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 31, 1997
Incorporating future costs in medical cost-effectiveness analysis: implications for the cost-effectiveness of the treatment of hypertensionM Johannesson, D Meltzer, R M O'Conor
British Journal of Urology|November 14, 1997
Willingness to pay for reduced incontinence symptomsM Johannesson, R M O'Conor, G Kobelt-Nguyen, et al.
Pharmacoeconomics|May 27, 1999
Urge incontinence. Quality of life and patients' valuation of symptom reductionR M O'Conor, M Johannesson, S L Hass, et al.
Pageof 1